Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: Telacebec
Date Designated: 01/13/2021
Orphan Designation: Treatment of Buruli ulcer
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Qurient Co., Ltd.
C-dong 8th Floor 242, Pangyo-ro, Bundang-gu, Seongnam-si
Gyeonggi-do, Korea 463-400
South Korea

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-